BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22585702)

  • 1. Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers.
    Park JH; Gail MH; Greene MH; Chatterjee N
    J Clin Oncol; 2012 Jun; 30(17):2157-62. PubMed ID: 22585702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
    Gail MH
    J Natl Cancer Inst; 2008 Jul; 100(14):1037-41. PubMed ID: 18612136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application values of genome-wide association studies in screening for breast cancer].
    Huang YB; Song FJ; Chen KX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):713-718. PubMed ID: 31238625
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.
    Clyde MA; Palmieri Weber R; Iversen ES; Poole EM; Doherty JA; Goodman MT; Ness RB; Risch HA; Rossing MA; Terry KL; Wentzensen N; Whittemore AS; Anton-Culver H; Bandera EV; Berchuck A; Carney ME; Cramer DW; Cunningham JM; Cushing-Haugen KL; Edwards RP; Fridley BL; Goode EL; Lurie G; McGuire V; Modugno F; Moysich KB; Olson SH; Pearce CL; Pike MC; Rothstein JH; Sellers TA; Sieh W; Stram D; Thompson PJ; Vierkant RA; Wicklund KG; Wu AH; Ziogas A; Tworoger SS; Schildkraut JM;
    Am J Epidemiol; 2016 Oct; 184(8):579-589. PubMed ID: 27698005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in predictive ability of common genetic variants by established strata: the example of breast cancer and age.
    Aschard H; Zaitlen N; Lindström S; Kraft P
    Epidemiology; 2015 Jan; 26(1):51-8. PubMed ID: 25380502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.
    Dite GS; Mahmoodi M; Bickerstaffe A; Hammet F; Macinnis RJ; Tsimiklis H; Dowty JG; Apicella C; Phillips KA; Giles GG; Southey MC; Hopper JL
    Breast Cancer Res Treat; 2013 Jun; 139(3):887-96. PubMed ID: 23774992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
    Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
    Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for developing prediction models from genome-wide association studies.
    Wu J; Pfeiffer RM; Gail MH
    Genet Epidemiol; 2013 Dec; 37(8):768-77. PubMed ID: 24166696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening.
    Jenkins MA; Makalic E; Dowty JG; Schmidt DF; Dite GS; MacInnis RJ; Ait Ouakrim D; Clendenning M; Flander LB; Stanesby OK; Hopper JL; Win AK; Buchanan DD
    Future Oncol; 2016 Feb; 12(4):503-13. PubMed ID: 26846999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on the use of multiple sclerosis risk genes for prediction.
    Jafari N; Broer L; van Duijn CM; Janssens AC; Hintzen RQ
    PLoS One; 2011; 6(12):e26493. PubMed ID: 22164203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
    Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
    J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.
    Gail MH
    J Natl Cancer Inst; 2009 Jul; 101(13):959-63. PubMed ID: 19535781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the clinical utility of genetic risk scores for targeted cancer screening.
    Conran CA; Shi Z; Resurreccion WK; Na R; Helfand BT; Genova E; Zheng SL; Brendler CB; Xu J
    J Transl Med; 2021 Jan; 19(1):41. PubMed ID: 33482857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.